Leishmania sp.
Image Gallery
[ (
||image_reduire{0,60}|inserer_attribut{alt,Cutaneous leishmaniasis})
]
[
(||image_reduire{0,60}|inserer_attribut{alt,Cutaneous leishmaniasis})
]
[
(||image_reduire{0,60}|inserer_attribut{alt,Leishmania donovani})
]
Pathology (leishmaniasis)
- cutaneous leishmaniasis
- mucocutaneous leishmaniasis
- visceral leishmaniasis
Types
Leishmania donovani
Leishmania infantum
References
Ravindran R, Ali N. Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis. Curr Mol Med. 2004 Sep;4(6):697-709. PMID: #15357218#
Roychoudhury K, Roy S. Role of chemokines in Leishmania infection. Curr Mol Med. 2004 Sep;4(6):691-6. PMID: #15357217#
Basu MK, Lala S. Macrophage specific drug delivery in experimental leishmaniasis. Curr Mol Med. 2004 Sep;4(6):681-9. PMID: #15357216#
Sukumaran B, Madhubala R. Leishmaniasis: current status of vaccine development. Curr Mol Med. 2004 Sep;4(6):667-79. PMID: #15357215#
Naderer T, Vince JE, McConville MJ. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Curr Mol Med. 2004 Sep;4(6):649-65. PMID: #15357214#
Shlomai J. The structure and replication of kinetoplast DNA. Curr Mol Med. 2004 Sep;4(6):623-47. PMID: #15357213#
Bates PA, Rogers ME. New insights into the developmental biology and transmission mechanisms of Leishmania. Curr Mol Med. 2004 Sep;4(6):601-9. PMID: #15357211#
Russell DG. Mycobacterium and Leishmania: stowaways in the endosomal network. Trends Cell Biol. 1995 Mar;5(3):125-8. PMID: #14732168#